REGN analyst scorecard · Regeneron Pharmaceuticals
68 rating changes on REGN in the last 12 months. 60% of bullish calls were right at 30 days; 50% of bearish ones. Street grade C on 49 scored calls. Consensus target $849, 7% above the last close.
Graded through 2026-09-14 · last close $794.29 (2026-09-14). Rebuilt every morning.
Holds on REGN, read: 3 cut to or raised to Hold (graded as the change) · 5 Holds whose target leaned 10%+ one way (graded that way, 40.0% right) · 18 true Holds, not graded.
Firm by firm
| Firm | Calls | Scored | Right | Accuracy | Grade | Avg 30d | Avg 90d | Latest | Date | Target |
|---|---|---|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | 5 | 5 | 4 | 80.0% | A | +5.9% | -1.0% | Overweight | 2026-07-31 | $795 |
| Canaccord Genuity | 4 | 4 | 3 | 75.0% | A | +14.0% | +25.3% | Buy | 2026-05-19 | $875 |
| Guggenheim | 5 | 5 | 3 | 60.0% | B | +7.8% | +4.9% | Buy | 2026-08-03 | $1030 |
| Truist Securities | 7 | 7 | 3 | 42.9% | D | -0.9% | -0.2% | Buy | 2026-07-31 | $772 |
| Citigroup | 4 | 3 | 3 | — | — | +12.6% | +27.9% | Neutral | 2026-08-03 | $740 |
| HSBC | 3 | 2 | 2 | — | — | +10.6% | +3.4% | Buy | 2026-09-10 | $920 |
| Leerink Partners | 2 | 1 | 1 | — | — | -3.5% | +28.0% | Market Perform | 2026-08-17 | $824 |
| Benchmark | 1 | 1 | 1 | — | — | +14.2% | — | Buy | 2026-07-07 | $185 |
| Oppenheimer | 1 | 1 | 1 | — | — | +4.3% | -6.1% | Outperform | 2026-02-02 | $865 |
| Evercore ISI Group | 1 | 1 | 1 | — | — | +4.2% | -1.2% | Outperform | 2026-01-22 | $875 |
| Morgan Stanley | 7 | 3 | 2 | — | — | +7.1% | +6.3% | Equal-Weight | 2026-07-31 | $758 |
| RBC Capital | 7 | 2 | 1 | — | — | +5.0% | +11.6% | Sector Perform | 2026-07-31 | $737 |
| Piper Sandler | 2 | 2 | 1 | — | — | +8.8% | +28.0% | Overweight | 2026-07-09 | $854 |
| BMO Capital | 2 | 2 | 1 | — | — | +1.1% | +18.5% | Outperform | 2026-05-18 | $730 |
| JPMorgan | 2 | 2 | 1 | — | — | +0.4% | +11.0% | Overweight | 2026-05-18 | $850 |
| Barclays | 2 | 2 | 1 | — | — | -7.3% | -9.5% | Overweight | 2026-04-30 | $917 |
| Wells Fargo | 7 | 2 | 0 | — | — | +3.6% | +8.7% | Equal-Weight | 2026-07-31 | $750 |
| Bank of America | 2 | 2 | 0 | — | — | +8.1% | +5.9% | Buy | 2026-01-07 | $860 |
| TD Cowen | 1 | 1 | 0 | — | — | -17.1% | -15.0% | Buy | 2026-04-23 | $960 |
| Bernstein | 1 | 1 | 0 | — | — | -7.8% | -12.8% | Outperform | 2026-04-08 | $921 |
| Scotiabank | 1 | 0 | 0 | — | — | +2.9% | +3.4% | Sector Perform | 2025-11-24 | $770 |
| UBS | 1 | 0 | 0 | — | — | +7.0% | +16.6% | Neutral | 2025-11-07 | $660 |
Dimmed rows have fewer than 4 scored calls on REGN — too few to grade.
Every call, last 12 months
| Date | Firm | Change | Action | Graded as | Price at call | Run before | +30d | +60d | +90d | Target · 90d check | Hit |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 | HSBC | Buy → Buy | maintained | Bullish | $793.26 | -0.5% | — | — | — | $920 | pending |
| 2026-08-17 | Leerink Partners | Market Perform → Market Perform | maintained | True hold · target +2% | $805.93 | +19.1% | — | — | — | $824 | not graded |
| 2026-08-03 | Citigroup | Neutral → Neutral | maintained | True hold · target -2% | $759.24 | +16.0% | +12.2% | — | — | $740 | not graded |
| 2026-08-03 | Guggenheim | Buy → Buy | maintained | Bullish | $759.24 | +16.0% | +12.2% | — | — | $1030 | ✓ |
| 2026-07-31 | RBC Capital | Sector Perform → Sector Perform | maintained | True hold · target -3% | $762.63 | +22.1% | +4.8% | — | — | $737 | not graded |
| 2026-07-31 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | True hold · target +0% | $762.63 | +22.1% | +4.8% | — | — | $758 | not graded |
| 2026-07-31 | Cantor Fitzgerald | Overweight → Overweight | maintained | Bullish | $762.63 | +22.1% | +4.8% | — | — | $795 | ✓ |
| 2026-07-31 | Wells Fargo | Equal-Weight → Equal-Weight | maintained | True hold · target -1% | $762.63 | +22.1% | +4.8% | — | — | $750 | not graded |
| 2026-07-31 | Truist Securities | Buy → Buy | maintained | Bullish | $762.63 | +22.1% | +4.8% | — | — | $772 | ✓ |
| 2026-07-21 | Guggenheim | Buy → Buy | maintained | Bullish | $675.19 | +10.7% | +22.4% | — | — | $1000 | ✓ |
| 2026-07-09 | Piper Sandler | Overweight → Overweight | maintained | Bullish | $667.95 | +8.4% | +21.0% | +21.3% | — | $854 | ✓ |
| 2026-07-08 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | Leans bullish · Equal-Weight, target +10% | $662.88 | +8.4% | +18.3% | +22.2% | — | $730 | ✓ |
| 2026-07-07 | RBC Capital | Sector Perform → Sector Perform | maintained | True hold · target +2% | $676.23 | +6.4% | +14.2% | +19.8% | — | $696 | not graded |
| 2026-07-07 | Truist Securities | Buy → Buy | maintained | Bullish | $676.23 | +6.4% | +14.2% | +19.8% | — | $769 | ✓ |
| 2026-07-07 | Benchmark | Hold → Buy | upgrade | Bullish | $676.23 | +6.4% | +14.2% | +19.8% | — | $185 | ✓ |
| 2026-07-06 | HSBC | Buy → Buy | maintained | Bullish | $649.81 | +2.3% | +18.3% | +27.4% | — | $880 | ✓ |
| 2026-07-06 | Cantor Fitzgerald | Overweight → Overweight | maintained | Bullish | $649.81 | +2.3% | +18.3% | +27.4% | — | $750 | ✓ |
| 2026-05-19 | Canaccord Genuity | Buy → Buy | maintained | Bullish | $630.30 | -16.0% | -3.2% | +6.6% | +27.9% | $875 close | ✗ |
| 2026-05-18 | BMO Capital | Outperform → Outperform | maintained | Bullish | $629.68 | -16.1% | -3.5% | +7.5% | +28.0% | $730 hit | ✗ |
| 2026-05-18 | Truist Securities | Buy → Buy | maintained | Bullish | $629.68 | -16.1% | -3.5% | +7.5% | +28.0% | $778 hit | ✗ |
| 2026-05-18 | JPMorgan | Overweight → Overweight | maintained | Bullish | $629.68 | -16.1% | -3.5% | +7.5% | +28.0% | $850 close | ✗ |
| 2026-05-18 | Piper Sandler | Overweight → Overweight | maintained | Bullish | $629.68 | -16.1% | -3.5% | +7.5% | +28.0% | $855 close | ✗ |
| 2026-05-18 | Wells Fargo | Equal-Weight → Equal-Weight | maintained | Leans bullish · Equal-Weight, target +11% | $629.68 | -16.1% | -3.5% | +7.5% | +28.0% | $700 hit | ✗ |
| 2026-05-18 | RBC Capital | Sector Perform → Sector Perform | maintained | Leans bullish · Sector Perform, target +12% | $629.68 | -16.1% | -3.5% | +7.5% | +28.0% | $707 hit | ✗ |
| 2026-05-18 | Citigroup | Buy → Neutral | downgrade | Bearish · cut to Neutral | $629.68 | -16.1% | -3.5% | +7.5% | +28.0% | $700 hit | ✓ |
| 2026-05-18 | Leerink Partners | Outperform → Market Perform | downgrade | Bearish · cut to Market Perform | $629.68 | -16.1% | -3.5% | +7.5% | +28.0% | $641 missed | ✓ |
| 2026-05-01 | Guggenheim | Buy → Buy | maintained | Bullish | $701.42 | -9.8% | -14.4% | -11.1% | +5.3% | $995 missed | ✗ |
| 2026-04-30 | RBC Capital | Sector Perform → Sector Perform | maintained | True hold · target +7% | $707.06 | -8.5% | -15.1% | -10.6% | -1.6% | $762 missed | not graded |
| 2026-04-30 | Barclays | Overweight → Overweight | maintained | Bullish | $707.06 | -8.5% | -15.1% | -10.6% | -1.6% | $917 missed | ✗ |
| 2026-04-30 | Truist Securities | Buy → Buy | maintained | Bullish | $707.06 | -8.5% | -15.1% | -10.6% | -1.6% | $796 missed | ✗ |
| 2026-04-30 | Wells Fargo | Equal-Weight → Equal-Weight | maintained | Leans bullish · Equal-Weight, target +13% | $707.06 | -8.5% | -15.1% | -10.6% | -1.6% | $800 missed | ✗ |
| 2026-04-23 | TD Cowen | Buy → Buy | maintained | Bullish | $766.02 | +3.3% | -17.1% | -20.0% | -15.0% | $960 missed | ✗ |
| 2026-04-23 | Cantor Fitzgerald | Overweight → Overweight | reiterated | Bullish | $766.02 | +3.3% | -17.1% | -20.0% | -15.0% | $800 missed | ✗ |
| 2026-04-10 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | True hold · target +6% | $748.87 | -3.3% | -4.8% | -17.7% | -10.8% | $796 missed | not graded |
| 2026-04-08 | Bernstein | Outperform → Outperform | maintained | Bullish | $775.53 | -0.8% | -7.8% | -21.2% | -12.8% | $921 missed | ✗ |
| 2026-03-31 | Truist Securities | Buy → Buy | maintained | Bullish | $772.64 | -1.2% | -8.5% | -22.3% | -18.2% | $801 missed | ✗ |
| 2026-03-06 | Barclays | Overweight | initiated | Bullish | $759.86 | -2.0% | +0.4% | -7.6% | -17.3% | $923 missed | ✓ |
| 2026-03-02 | RBC Capital | Sector Perform → Sector Perform | maintained | True hold · target -3% | $790.81 | +6.7% | -1.7% | -11.3% | -24.0% | $765 hit | not graded |
| 2026-02-09 | Guggenheim | Buy → Buy | maintained | Bullish | $780.28 | -2.0% | -0.7% | -4.0% | -8.7% | $975 missed | ✗ |
| 2026-02-02 | JPMorgan | Overweight → Overweight | maintained | Bullish | $755.02 | -2.7% | +4.3% | +1.1% | -6.1% | $950 missed | ✓ |
| 2026-02-02 | Oppenheimer | Outperform → Outperform | reiterated | Bullish | $755.02 | -2.7% | +4.3% | +1.1% | -6.1% | $865 missed | ✓ |
| 2026-02-02 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | True hold · target +1% | $755.02 | -2.7% | +4.3% | +1.1% | -6.1% | $769 missed | not graded |
| 2026-02-02 | Wells Fargo | Equal-Weight → Equal-Weight | maintained | True hold · target +6% | $755.02 | -2.7% | +4.3% | +1.1% | -6.1% | $800 missed | not graded |
| 2026-02-02 | Cantor Fitzgerald | Overweight → Overweight | maintained | Bullish | $755.02 | -2.7% | +4.3% | +1.1% | -6.1% | $800 missed | ✓ |
| 2026-02-02 | Truist Securities | Buy → Buy | maintained | Bullish | $755.02 | -2.7% | +4.3% | +1.1% | -6.1% | $818 missed | ✓ |
| 2026-01-22 | Evercore ISI Group | Outperform → Outperform | maintained | Bullish | $755.51 | -3.8% | +4.2% | -2.5% | -1.2% | $875 missed | ✓ |
| 2026-01-08 | Truist Securities | Buy → Buy | maintained | Bullish | $801.01 | +15.7% | -2.6% | -2.4% | -3.2% | $820 missed | ✗ |
| 2026-01-07 | Bank of America | Underperform → Buy | upgrade | Bullish | $812.27 | +15.5% | -3.3% | -3.8% | -6.4% | $860 missed | ✗ |
| 2025-12-12 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | True hold · target +3% | $741.29 | +8.7% | +3.6% | +1.8% | +0.7% | $768 hit | not graded |
| 2025-12-10 | Wells Fargo | Equal-Weight → Equal-Weight | maintained | True hold · target +2% | $726.21 | +10.9% | +9.7% | +7.5% | +6.3% | $745 hit | not graded |
| 2025-12-04 | Canaccord Genuity | Buy → Buy | maintained | Bullish | $722.80 | +15.1% | +5.6% | +4.5% | +8.9% | $1057 missed | ✓ |
| 2025-12-04 | BMO Capital | Outperform → Outperform | maintained | Bullish | $722.80 | +15.1% | +5.6% | +4.5% | +8.9% | $850 close | ✓ |
| 2025-12-03 | Morgan Stanley | Overweight → Equal-Weight | downgrade | Bearish · cut to Equal-Weight | $723.67 | +12.7% | +7.3% | +4.3% | +5.9% | $767 hit | ✗ |
| 2025-11-24 | Scotiabank | Sector Perform → Sector Perform | maintained | True hold · target +1% | $761.45 | +31.8% | +2.9% | -1.0% | +3.4% | $770 hit | not graded |
| 2025-11-24 | HSBC | Buy | initiated | Bullish | $761.45 | +31.8% | +2.9% | -1.0% | +3.4% | $890 missed | ✓ |
| 2025-11-20 | Wells Fargo | Equal-Weight → Equal-Weight | maintained | True hold · target -5% | $737.00 | +27.2% | +5.8% | -0.4% | +7.5% | $700 missed | not graded |
| 2025-11-07 | UBS | Neutral → Neutral | maintained | True hold · target +0% | $657.53 | +16.6% | +7.0% | +18.1% | +16.6% | $660 missed | not graded |
| 2025-10-29 | Citigroup | Buy → Buy | maintained | Bullish | $652.91 | +16.4% | +19.5% | +19.5% | +18.1% | $700 hit | ✓ |
| 2025-10-29 | RBC Capital | Sector Perform → Sector Perform | maintained | True hold · target +8% | $652.91 | +16.4% | +19.5% | +19.5% | +18.1% | $708 hit | not graded |
| 2025-10-29 | Wells Fargo | Equal-Weight → Equal-Weight | maintained | True hold · target -5% | $652.91 | +16.4% | +19.5% | +19.5% | +18.1% | $615 missed | not graded |
| 2025-10-29 | Cantor Fitzgerald | Overweight → Overweight | maintained | Bullish | $652.91 | +16.4% | +19.5% | +19.5% | +18.1% | $740 hit | ✓ |
| 2025-10-29 | Guggenheim | Buy → Buy | maintained | Bullish | $652.91 | +16.4% | +19.5% | +19.5% | +18.1% | $865 close | ✓ |
| 2025-10-29 | Bank of America | Underperform → Underperform | maintained | Bearish | $652.91 | +16.4% | +19.5% | +19.5% | +18.1% | $627 missed | ✗ |
| 2025-10-23 | Canaccord Genuity | Buy → Buy | maintained | Bullish | $575.69 | +1.4% | +32.3% | +35.4% | +30.2% | $850 close | ✓ |
| 2025-10-14 | Canaccord Genuity | Buy → Buy | maintained | Bullish | $572.60 | — | +21.4% | +31.4% | +34.1% | $850 close | ✓ |
| 2025-10-13 | Citigroup | Buy → Buy | maintained | Bullish | $557.73 | — | +22.2% | +32.9% | +37.7% | $660 hit | ✓ |
| 2025-10-10 | Morgan Stanley | Overweight → Overweight | maintained | Bullish | $564.63 | — | +16.0% | +22.7% | +41.9% | $756 hit | ✓ |
| 2025-10-08 | RBC Capital | Sector Perform → Sector Perform | maintained | Leans bullish · Sector Perform, target +24% | $563.86 | — | +16.6% | +24.7% | +37.7% | $704 hit | ✓ |
Also in Biotech
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How the grading works
Every sell-side rating change from the last 365 days is priced the day it lands and checked again 30, 60 and 90 days later. A call is a hit when the stock moved in the called direction at 30 days. Buy- and Sell-side ratings call their own direction. A Hold is read, not waved through: a downgrade to Hold is graded as a bearish call and an upgrade to Hold as a bullish one, and a maintained Hold whose price target sits 10%+ above the price leans bullish (10%+ below, leans bearish) and is graded that way. A Hold with a target close to the price is a true Hold and is not graded at all. Every call with a price target also gets a target check 90 days later: hit (reached it or within 5%), close (covered at least half the distance) or missed. A firm's accuracy on a single name prints only after 4 scored calls, and a firm gets its own page only after 10 scored calls across every covered name — below that a percentage is noise. "Run before the call" is the stock's move over the 30 calendar days before the rating landed. Data: Yahoo Finance rating history and daily closes, rebuilt each morning. Nothing on this page is advice.
Get the 7 AM brief
The AM take, today's docket and the Street's calls — one email, weekdays, before the open.